Skip to main content

Prof Jerome Amir Singh (BA, LLB, LLM, MHSc, PhD) serves as the Principal Investigator of the Scientific Advisory Group on Emergencies (SAGE), which operates under the auspices of the Academy of Sciences of South Africa (ASSAf). He is Adjunct Professor in the Dalla Lana School of Public Health, University of Toronto, Toronto, Canada and Honorary Research Fellow at the Howard College School of Law, University of KwaZulu-Natal, Durban, South Africa. Prof Singh serves as an ad hoc Consultant to several United Nation entities, including the World Health Organisation (WHO), UNAIDS, and UNICEF. He currently serves on several advisory and oversight bodies related to humanitarian and emergency issues, including the International Ethics Review Board of Médecins Sans Frontières (MSF). He has served as a consultant to the WHO on several global health issues, including H5N1, XDR-TB, HIV, malaria, Artificial Intelligence, and gene drive research. He has also served as an advisor to the WHO on identifying and connecting known, new or emerging issues that could significantly impact global health. In 2017, Prof Singh was appointed by the WHO Director-General (DG) to serve as a member of WHO’s International Health Regulations ‘Public Health Emergency of International Concern’ Expert Roster. In 2020, he was appointed by the WHO DG to serve as a member of the WHO’s Ad Hoc Research Ethics Review Committee (ERC) for COVID-19. He also serves on the WHO COVID-19 Ethics & Governance Working Group, and the WHO Technical Advisory Group (TAG) for Emergency Use Listing of COVID-19 vaccines. Prof Singh co-chairs the US NIH-funded Ethics Working Group of the HIV Prevention Trial Network (HPTN) and serves as a member of the South African National AIDS Council (SANAC) Legal and Human Rights Technical Task Team, and the Bioethics Advisory Panel of the South African Medical Research Council (SA MRC). He has previously co-directed the Ethical, Social, and Cultural Issues Advisory Services of the Bill and Melinda Gates Foundation’s Grand Challenges in Global Health Initiative.